University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 12 of 27
The Biobehavioral Impact of Diet Quality on Affect and Craving
NCT04105712
Happy@Home: Delivering iCBT With Homecare Workers to At-Home Seniors
NCT04267289
Ventricular Assist Device (VAD) Infection Prevention Survey
NCT03843021
Adolescent Interventions to Manage Self-regulation of T1D (AIMS T1D)
NCT03688919
Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus
NCT03852576
Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy
NCT03826342
Cognitive Behavioral Therapy for Insomnia (CBTI) in GERD Patients With Insomnia
NCT03904472
Stimulation to Improve Memory
NCT03875326
Reach Out: Emergency Department-Initiated Hypertension Behavioral Intervention Connecting Multiple Health Systems
NCT03422718
Task Control Circuit Targets for Obsessive Compulsive Behaviors in Children
NCT03584945
Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease
NCT03839082
Tracking Our Lives Study
NCT04052529
An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART
NCT03838198
Burst Spinal Cord Stimulation (Burst-SCS) Study
NCT03718325
Electrical Impedance Tomography for Optimization of Positive End-Expiratory Pressure: Acute Respiratory Distress Syndrome
NCT03793842
Stroke Ready: A Stroke Preparedness Brief Intervention
NCT03831451
PTNS on Urinary and Global Quality of Life in MS Patients
NCT04063852
My MS Toolkit: a Symptom Self-management Program for Multiple Sclerosis
NCT03708276
MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation
NCT03626857
Identification of Biomarkers in Spinocerebellar Ataxia 3
NCT03885167
The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder
NCT03715465
Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy
NCT03749434
Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome
NCT03794908
Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis
NCT04335370
Multimodal Ocular Imaging in Neurodegeneration
NCT03699644
Care Coordination and Proactive Care to Improve Utilization of Resources and Reduce Expenditure in High Risk Inflammatory Bowel Disease (IBD) Patients
NCT04796571
Exercise and the Receptor for Advanced Glycation End Products (RAGE)
NCT03534687
Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)
NCT03724032
Desensitization to Reduce Oral Hypersensitivity and Improve Intake for Children With Feeding Disorders
NCT03739047
Long-term Surgical Therapeutic Outcomes of Peri-Implantitis
NCT03772652
Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients
NCT03705260
Epidural Catheter Thread Between Two Different Vendors
NCT03722446
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
NCT03621761
Instrumentation Effectiveness of Modified, Area-Specific Hand Scalers During Non-Surgical Periodontal Therapy
NCT03729167
Longitudinal Assessment of Cartilage Injury and Remodeling After Anterior Cruciate Ligament Rupture and Reconstruction:
NCT03497780
Assessing the Safety and Efficacy of a Novel Subcutaneous Implant Insertion Device on Healthy Adults
NCT03621787
Warning Labels and College Students' Sugar-Sweetened Beverage Intake
NCT04435145
Reducing Non-Medical Opioid Use: An Automatically Adaptive mHealth Intervention
NCT02990377
Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees
NCT03711266
Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts
NCT03621735
The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)
NCT03729479
Testing a Life Skills Application to Address Interpersonal Relationships in College (MKit)
NCT03715426
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
NCT03695913
The OPT-IN Project
NCT03526380
Brain Stimulation and Cognitive Training
NCT03338673
Effectiveness of Silver Diamine Fluoride (SDF) in Arresting Cavitated Caries Lesions
NCT03649659
Using Peer Support to Aid in Prevention and Treatment in Prediabetes
NCT03689530
Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition
NCT03514134
Acupressure for Pain and Opioid Use Among Breast Cancer Patients
NCT03655600
Medical Decisions in the Hospital Setting- M-Safety
NCT03757884
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.